← All companies

CELZ

Creative Medical Technology Holdings, Inc.

CELZ Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$0.65

-0.01 -1.51%

Key statistics

from XBRL data in SEC filings

Market cap

$2.42M

Revenue (TTM)

$3.00K

Net income (TTM)

-$5.76M

EPS (TTM)

$-2.07

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$5.72M

Total assets

$6.44M

Gross margin

66.9%

52-week range

$0.62 – $6.25

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Unregistered sale of equity; Director or officer change Jul 2, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 24, 2026 10-K Fiscal year ended 2025-12-31 Mar 20, 2026 8-K Shareholder vote results Dec 31, 2025 8-K Shareholder vote results Dec 19, 2025 8-K Director or officer change Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Entered a material agreement; Unregistered sale of equity Oct 31, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Shareholder vote results May 6, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 25, 2025 8-K Delisting notice or listing-rule failure Apr 11, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 4, 2025 10-K/A Fiscal year ended 2024-12-31 Mar 19, 2025 8-K Director or officer change Mar 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 14, 2025 8-K Entered a material agreement; Unregistered sale of equity Mar 7, 2025 8-K Amended charter or bylaws; Shareholder vote results Dec 26, 2024 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Entered a material agreement Oct 23, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Shareholder vote results Jul 25, 2024 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws; Item 5.08 May 17, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 29, 2024 10-K Fiscal year ended 2023-12-31 Mar 22, 2024 8-K Shareholder vote results Dec 20, 2023 10-Q Quarter ended 2023-09-30 Nov 14, 2023 10-Q Quarter ended 2023-06-30 Aug 11, 2023 8-K Other events Jun 28, 2023 8-K Modified rights of security holders; Amended charter or bylaws; Other events Jun 9, 2023 10-Q Quarter ended 2023-03-31 May 12, 2023 10-K/A Fiscal year ended 2022-12-31 May 1, 2023 10-K Fiscal year ended 2022-12-31 Mar 31, 2023 8-K Shareholder vote results Dec 19, 2022 10-Q Quarter ended 2022-09-30 Nov 10, 2022 10-Q Quarter ended 2022-06-30 Aug 12, 2022 8-K Delisting notice or listing-rule failure Jul 14, 2022